71 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

I5X

Precigen
US$1.413.7%61.1%US$347.2mUS$9.10PS55.8xE55.5%n/a

SGT

Seagen
US$208.603.4%74.0%US$43.2bUS$208.75PS18.8xE71.8%n/a

4LN2

Capricor Therapeutics
US$5.74-0.9%50.7%US$200.3mUS$18.89PS8xE59.4%n/a

1AE

argenx
€365.005.6%10.4%€21.9b€433.17PS18.7xE56.2%n/a

6IB

Innovent Biologics
HK$4.06-15.1%-6.5%HK$58.4bHK$6.23PS8.7xE52.1%n/a

YDO1

Madrigal Pharmaceuticals
US$228.00-7.4%4.6%US$4.9bUS$362.43PB12.2xE62.2%n/a

FYB

Formycon
€46.703.5%-30.3%€756.2m€102.35PS11xE72.1%n/a

78F0

Freeline Therapeutics Holdings
US$6.000%n/aUS$28.3mUS$6.02PS45.4xE57.2%n/a

B00

Biocept
US$6.800%-80.4%US$1.6mn/aPB0.7xE65.8%n/a

UXI

Cyclacel Pharmaceuticals
US$3.260%-58.6%US$3.2mUS$218.47PS8.2xE52.2%n/a

LWB1

Mesoblast
AU$1.870%-67.1%AU$380.9mAU$3.57PS33.2xE65.5%n/a

H6Z

YS Biopharma
US$0.56-9.8%n/aUS$118.6mUS$3.78PS1.5xE68.3%n/a

7AY1

Actinium Pharmaceuticals
US$8.3545.2%0.2%US$255.4mUS$23.02PB5.9xE63.0%n/a

XUP

Genfit
€3.210.8%-13.9%€165.3m€9.04PS5.7xE52.3%n/a

VPA1

AVEO Pharmaceuticals
US$13.770.7%358.7%US$521.4mUS$13.77PS5.5xE123.0%n/a

6XP

Xspray Pharma
kr5.000%n/akr1.4bn/aPB2.8xE124.4%n/a

P7N1

Sierra Oncology
€52.000%217.1%€1.3bn/aPB4.9xE64.3%n/a

137

Aldeyra Therapeutics
US$2.707.1%-67.0%US$171.4mUS$8.76PB1.4xE51.9%n/a

GON

Geron
US$3.11-0.3%49.7%US$2.0bUS$4.78PS8213xE62.1%n/a

2LB

Iovance Biotherapeutics
US$14.079.0%169.1%US$4.2bUS$24.35PS3528.3xE61.7%n/a

PCJ

Abeona Therapeutics
US$6.76-7.3%213.0%US$208.2mUS$18.65PS59.5xE60.7%n/a

YP1B

Immutep
AU$0.215.0%39.5%AU$457.7mn/aPS116.4xE62.1%n/a

ATQP

Vericel
US$42.005.5%61.1%US$2.3bUS$46.63PS11.5xE49.4%n/a

7UM

Ultimovacs
kr0.632.3%-93.5%kr268.4mn/aPB1xE60.6%n/a
Page 2 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.